Genmab — Januar 2018
-
Hvor hurtigt skal man normalt svare i tilfælde af bud? JNJ næste tal bliver afgørende om kursudvikling
-
Eller rettere det giver analytikere et praj ,, så de kan se udviklingen tyderligere
-
Hej gutter, kan I ikke kommentere på David Myginds indlæg i debat tråden? Det fortjener han. http://www.proinvestor.com/debat/76029
-
God morgen

-
God morgen.

-
Pesionisten...Vi er enige.
-
Godmorgen

-
if you are interested in the Stellungnahme der AkdÄ zu Daratumumab ( Arzneimittelkommission der deutschen Ärzteschaft) https://www.akdae.de/Service/Newsletter/Archiv/News/Archiv/2018-01.html
-
Johnson & Johnson (JNJ) Management Presents at 36th Annual JPMorgan Healthcare Conference 2018 - Brokers Conference Transcript - https://seekingalpha.com/article/4136072-johnson-and-johnson-jnj-management-presents-36th-annual-jpmorgan-healthcare-conference-2018?part=single
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind